Quarterly report pursuant to Section 13 or 15(d)

Description of Business and Summary of Significant Accounting Policies (Tables)

v3.10.0.1
Description of Business and Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of antidilutive securities excluded from computation of diluted net loss per share
    September 30,
2018
    September 30,
2017
 
Options     7,668,231       6,156,361  
Warrants     56,013,474       27,220,388  
Total     63,681,705       33,376,749  
Schedule of impacts to consolidated statements of cash flows
    Previously Reported     Adjustment     As Revised  
Net cash provided by (used in) investing activities   $ (379,621 )   $ 356,141     $ (23,480 )
Summary of cash and cash equivalent and restricted cash

    September 30,
2018
  December 31,
2017
  September 30,
2017
Cash and cash equivalents   $ 14,805,472     $ 17,399,636     $ 20,541,955  
Restricted cash – current     40,055       -          
Restricted cash     390,940       390,940       390,874  
Cash and cash equivalent and restricted cash   $ 15,236,467     $ 17,790,576     $ 20,932,829